Founded in 2013, with extensive medical experience, Ventinova Medical is a company that develops and markets innovative products for airway management and patient ventilation.
We believe in creating a new ventilation concept through revolutionary products. Products that are more than just upgrades of current standard practice.
With our knowledge and access to state-of-the-art technology we are able to develop ideas and solutions that surprise the medical field. The philosophy behind all our products is active expiration or expiration by suction.
Inventions and Innovations
The credit for inventing the concept behind our mechanical ventilator, Evone, and manual ventilator, Ventrain, goes to Prof. Dr. D. Enk, MD. PhD, anesthesiologist at the University Hospital Munster.
Specializing in airway management for more than twenty years, Prof. Enk fully committed himself to the research on a flow-controlled ventilator, allowing safe and efficient ventilation of patients through a ‘straw’, even in the case of airway obstruction.
His initial idea has been further developed in close collaboration between Ventinova Medical and Prof. Enk’s clinical research group.
Ventinova Medical develops and markets innovative medical devices. The products that are currently on the market are: mechanical ventilator, Evone; manual ventilator, Ventrain; the ultrathin tube, Tritube; and 2 mm transtracheal catheter, Cricath.
We believe that diversity is the strength of our team. It consists of experts in research, development and marketing, production and regulatory affairs.
The development of Ventrain is enabled with contribution from The European Regional Development Fund in the framework of OP-Zuid and the Dutch government.
For the development of Evone, Ventinova Medical has received funding from the European Union’s Horizon 2020 Research and Innovation Programme and Innovation Credit from the Dutch Ministry of Economic Affairs and Climate Policy.
Do you want to know more about us or our products?
The CE mark of Evone in 2017. Well over 300 patient cases in 10 countries with Evone and Tritube. Distributors across Europe ready to demonstrate and sell Evone). The completion of four randomized controlled trials and one multi center observational study. The...